Regression of optic disc neovascularization in patients with behçet's uveoretinitis after infliximab therapy

Journal of Ocular Pharmacology and Therapeutics

Volumn 26, Issue 6, 2010, Pages 627-630

  Kawaguchi, Tatsushi ^a   Sugita, Sunao ^a   Yamada, Yukiko ^a   Miyanaga, Masaru ^a   Mochizuki, Manabu ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; INFLIXIMAB; PREDNISOLONE;

ACNE; ADULT; ANTERIOR EYE CHAMBER; ARTICLE; BEHCET DISEASE; BLURRED VISION; CAPILLARY LEAK SYNDROME; CASE REPORT; DISEASE COURSE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EYE INFLAMMATION; FLUORESCENCE ANGIOGRAPHY; FOOT AND MOUTH DISEASE; HUMAN; HYPOPYON; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY CELL; MALE; OCULAR FIBROSIS; OPHTHALMOSCOPY; OPTIC DISK; REMISSION; RETINA CAPILLARY; RETINA MACULA CYSTOID EDEMA; RETINA MACULA LUTEA; RETINA NEOVASCULARIZATION; RETINA VASCULITIS; SLIT LAMP; TREATMENT RESPONSE; UVEITIS; UVEORETINITIS; VISUAL ACUITY; VITREOUS FLOATERS; VITREOUS HEMORRHAGE;

ADULT; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BEHCET SYNDROME; FLUORESCEIN ANGIOGRAPHY; HUMANS; INFUSIONS, INTRAVENOUS; MALE; NEOVASCULARIZATION, PATHOLOGIC; OPTIC DISK; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 78649693340     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2010.0031     Document Type: Article

References (13)

1. Tugal-Tutkun, I., Onal, S., Altan-Yaycioglu, R., Huseyin Altunbas, H., and Urgancioglu, M. Uveitis in Behçet's disease: an analysis of 880 patients. Am. J. Ophthalmol. 138:373-380, 2004.
2. Tugal-Tutkun, I., Onal, S., Altan-Yaycioglu, R., Kir, N., and Urgancioglu, M. Neovascularization of the optic disc in Behçet's disease. Jpn. J. Ophthalmol. 50:256-265, 2006.
3. Ohno, S., Nakamura, S., Hori, S., et al. Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J. Rheumatol. 31:1362-1368, 2004.
4. Tugal-Tutkun, I., Mudun, A., Urgancioglu, M., et al. Efficacy of infliximab in the treatment of uveitis that is resistant to treatment with the combination of azathioprine, cyclospor-ine, and corticosteroids in Behçet's disease: an open-label trial. Arthritis Rheum. 52:2478-2484, 2005.
5. Yamada, Y., Sugita, S., Tanaka, H., et al. Comparison of infliximab versus cyclosporine during the initial 6-month treatment period in Behçet's disease. Br. J. Ophthalmol. 94: 284-288, 2010.
6. Tabbara, K.F., and Al-Hemidan, A.I. Infliximab effects compared to conventional therapy in the management of retinal vasculitis in Behçet disease. Am. J. Ophthalmol. 146: 845-850, 2008.
7. Giansanti, F., Barbera, M.L., Virgili, G., et al. Infliximab for the treatment of posterior uveitis with retinal neovascular-ization in Behçet's disease. Eur. J. Ophthalmol. 14:445-448, 2004.
8. Sanislo, S.R., Lowder, C.Y., Kaiser, P.K., et al. Corticosteroid therapy for optic disc neovascularization secondary to chronic uveitis. Am. J. Ophthalmol. 130:724-731, 2000.
9. Stuebiger, N., Koetter, I., and Zierhut, M. Complete regression of retinal neovascularization after therapy with inter-feron alfa in Behçet's disease. Br. J. Ophthalmol. 84:1437-1438, 2000.
10. Koetter, I., Zierhut, M., Eckstein, A.K., et al. Human re-combinant interferon alfa-2a for the treating of Behçet's disease with sight threatening posterior or panuveitis. Br. J. Ophthalmol. 87:423-431, 2003.
11. Rosenbaum, J.T., Howes Jr., E.L., Rubin, R.M., and Samples, J.R. Ocular inflammatory effects of intravitreally-injected tumor necrosis factor. Am. J. Pathol. 133:47-53, 1988.
12. Gül, A. Behçet's disease: an update on the pathogenesis. Clin. Exp. Rheumatol. 19(Suppl 24):S6-S12, 2001.
13. Ahn, J.K., Yu, H.G., Chung, H., and Park, Y.G. Intraocular cytokine environment in active Behçet uveitis. Am. J. Oph-thalmol. 142:429-434, 2006.